Stay updated on Effect of Dupilumab on Contact Dermatitis: Clinical Trial
Sign up to get notified when there's something new on the Effect of Dupilumab on Contact Dermatitis: Clinical Trial page.

Latest updates to the Effect of Dupilumab on Contact Dermatitis: Clinical Trial page
- Check4 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the page otherwise remains a 403 error page.SummaryDifference0.2%

- Check11 days agoChange DetectedA site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check18 days agoChange DetectedThe footer revision label was updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check25 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1; the clinical trial record page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page displays a 403 Forbidden error page with standard header and footer, replacing the previous study-record content and navigation.SummaryDifference17%

- Check67 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a minor platform or template update to the study record page.SummaryDifference0.1%

Stay in the know with updates to Effect of Dupilumab on Contact Dermatitis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effect of Dupilumab on Contact Dermatitis: Clinical Trial page.